Atlas Trials

A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)

Clinical trial NCT01674361 · COMPLETED

Trial details

NCT number
NCT01674361
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder
Start date
2012-12-31
Primary completion
2015-04-30
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.